Class Actions · Mass Torts · Securities FraudCall (918) 238-6445

Attorney advertisingBriefMass Torts

FDA classifies Cardinal Health infusion-kit correction as Class I recall

Responsible attorney: Lou Schwartz, Schwartz & Associates, PC, Atlanta, Georgia. intake@snalawyers.com

The FDA announced it has raised to Class I, its most serious recall category, Cardinal Health's correction of Presource procedure kits that contain BD Alaris pump infusion sets already subject to a separate recall. The agency says the affected infusion sets can cause unpredictable pump behavior, including under-infusion, over-infusion, or failure to infuse, risks the agency has described as most serious for neonates and children in hospital settings. Cardinal Health has instructed hospital customers to quarantine the kits and remove and discard the recalled infusion sets before continued use. As of mid-August 2026, no serious injuries or deaths had been reported in connection with the issue, according to the FDA.

Why it matters. A Class I designation covering widely used hospital infusion kits, with heightened risk to neonatal and pediatric patients, can generate product-liability and wrongful-death inquiries that plaintiff firms track alongside other FDA device recalls.

Ask the intake assistant about this

Sources

  1. FDA recall notice
  2. ad-hoc-news.de secondary

Briefs summarize public developments. Unless stated otherwise, the firm is not counsel in the matters described, and allegations are not findings.

General information, not legal advice. Reading this article or using the intake assistant does not create an attorney-client relationship.

If something happened to more people than you, tell us.

Many class actions begin with one person who noticed a pattern. Reviewing your information costs nothing and creates no obligation.